- Home
- DRUG vs EBF Comparison
DRUG vs EBF Comparison
Compare DRUG & EBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- EBF
- Stock Information
- Founded
- DRUG 2019
- EBF 1909
- Country
- DRUG United States
- EBF United States
- Employees
- DRUG N/A
- EBF N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- EBF Office Equipment/Supplies/Services
- Sector
- DRUG Health Care
- EBF Consumer Discretionary
- Exchange
- DRUG Nasdaq
- EBF Nasdaq
- Market Cap
- DRUG 484.7M
- EBF 448.8M
- IPO Year
- DRUG N/A
- EBF N/A
- Fundamental
- Price
- DRUG $69.38
- EBF $16.92
- Analyst Decision
- DRUG Strong Buy
- EBF
- Analyst Count
- DRUG 9
- EBF 0
- Target Price
- DRUG $81.67
- EBF N/A
- AVG Volume (30 Days)
- DRUG 108.7K
- EBF 169.6K
- Earning Date
- DRUG 08-11-2025
- EBF 09-22-2025
- Dividend Yield
- DRUG N/A
- EBF 5.91%
- EPS Growth
- DRUG N/A
- EBF 3.59
- EPS
- DRUG N/A
- EBF 1.63
- Revenue
- DRUG N/A
- EBF $388,344,000.00
- Revenue This Year
- DRUG N/A
- EBF $0.96
- Revenue Next Year
- DRUG N/A
- EBF N/A
- P/E Ratio
- DRUG N/A
- EBF $10.57
- Revenue Growth
- DRUG N/A
- EBF N/A
- 52 Week Low
- DRUG $23.18
- EBF $16.85
- 52 Week High
- DRUG $70.23
- EBF $22.29
- Technical
- Relative Strength Index (RSI)
- DRUG 68.34
- EBF 33.43
- Support Level
- DRUG $62.21
- EBF $17.02
- Resistance Level
- DRUG $70.23
- EBF $17.62
- Average True Range (ATR)
- DRUG 6.00
- EBF 0.39
- MACD
- DRUG 0.52
- EBF -0.07
- Stochastic Oscillator
- DRUG 96.01
- EBF 5.81
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About EBF Ennis Inc.
Ennis Inc is a manufacturer and supplier of print products for the wholesale trade. The company's products include advertising specialties, business forms and supplies, commercial printing, eCommerce solutions, envelopes, labels and tags, and folders and packaging. Its products include snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure-sensitive products in short, medium and long runs under the following labels: Ennis, Royal Business Forms, Block Graphics, 360 Custom LabelsSM, ColorWorx, Enfusion, among others.